MINNEAPOLIS, May 28 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today that it will release financial results for the fourth quarter and the fiscal year ended March 31, 2008, at the market close on Tuesday, June 3, 2008. The Company will host a conference call to discuss these results on Tuesday, June 3, 2008 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 800-218-0204 (domestic) or 303-262-2130 (international). An audio replay will be available for thirty days following the call at 800-405-2236 (domestic) or 303-590-3000 (international), with the passcode 11115072#.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a
medical device company that develops, manufactures and markets innovative
proprietary products for the treatment of voiding dysfunctions. Our primary
focus is the commercialization of our Urgent PC(R) system, which we believe
is the only FDA-approved minimally invasive nerve stimulation device
designed for office-based treatment of symptoms often associated with
overactive bladder. We also offer Macroplastique(R) Implants, a bulking
agent for the treatment of urinary incontinence. Please visit Uroplasty,
Inc. at http://www.uroplasty.com.
For Further Information:
Uroplasty, Inc. EVC Group
David Kaysen, President and CEO, or Dahlia Baliey (Investors)
Medi Jiwani, Vice President, CFO, and 415.896.6820
Treasurer, Chris Gale (Media)
|SOURCE Uroplasty, Inc.|
Copyright©2008 PR Newswire.
All rights reserved